Steroidal Pyrimidines and Dihydrotriazines as Novel Classes of Anticancer Agents against Hormone-Dependent Breast Cancer Cells
Alexander M. Scherbakov(Gause Institute of New Antibiotics Russian Academy of Medical Sciences), Yulia A. Volkova(N.D. Zelinsky Institute of Organic Chemistry)
Cited by 65
Related Papers
The phenomenon of acquired resistance to metformin in breast cancer cells: The interaction of growth pathways and estrogen receptor signaling
|IUBMB Life|2016|60
Novel pentacyclic derivatives and benzylidenes of the progesterone series cause anti-estrogenic and antiproliferative effects and induce apoptosis in breast cancer cells
|Investigational New Drugs|2023|29
Targeting hormone-resistant breast cancer cells with docetaxel: a look inside the resistance
|Cancer Drug Resistance|2023|18
Honokiol inhibits the growth of hormone-resistant breast cancer cells: its promising effect in combination with metformin
|Research in Pharmaceutical Sciences|2023|10
Antiproliferative effects of 13α/β-steroids on triple-negative MDA-MB-231 breast cancer cells: unraveling intracellular signaling without ERα
|Brazilian Journal of Pharmaceutical Sciences|2023|6